secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2023-12-18T23:59:59+00:00
Accession:  0001683168-23-008898
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharmaceuticals enters into ATM equity distribution agreement with Maxim Group for up to $392,077
--------------------------------------------------------------------------------

- ATM facility allows Sonoma to sell up to $392,077 of common stock through Maxim Group.
- Maxim receives 3% commission per sale plus expense reimbursement up to $20,000.
- Sales under effective S-3 registration statement (333-275311) declared effective Nov 20, 2023.
- Company not obligated to sell any shares; no assurance of price, timing, or amount.
- Agreement terminates upon full sale of shares or earlier per its terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823008898/0001683168-23-008898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316823008898/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-008898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer